Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ayaka Kojima

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 21, 2022
Species and tissue differences in regorafenib glucuronidationAyaka Kojima, Masayuki Nadai, Miki Katoh
Drug Metabolism and Pharmacokinetics|February 9, 2025
Substrate inhibition potential of arachidonic acid on 14,15-epoxidation, a biological drug developmental target, mediated by recombinant human cytochrome P450 2J2 and 2C8 enzymesAyaka Kojima, Masayuki Nadai, Hiroshi Yamazaki, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 12, 2022
Species differences in oxidative metabolism of regorafenibAyaka Kojima, Ayuka Sogabe, Masayuki Nadai, et al.
Drug Metabolism and Pharmacokinetics|September 30, 2025
Tyrosine kinase inhibitors, nilotinib and radotinib, suppress both catalytic function and mRNA expression of human cytochrome P450 2J2 and 2C8Ayaka Kojima, Masayuki Nadai, Hiroshi Yamazaki, et al.
Angewandte Chemie (International Ed. in English)|January 31, 2014
A core-expanded subphthalocyanine analogue with a significantly distorted conjugated surface and unprecedented propertiesSoji Shimizu, Shota Nakano, Ayaka Kojima, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 17, 2022
Effects of multi-kinase inhibitors on the activity of cytochrome P450 2J2Ayaka Kojima, Masayuki Nadai, Norie Murayama, et al.
Biopharmaceutics & Drug Disposition|August 24, 2022
Changes in uridine 5'-diphospho-glucuronosyltransferase 1A6 expression by histone deacetylase inhibitor valproic acidYukiko Sakakibara, Ayaka Kojima, Yuki Asai, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 6, 2024
Effects of tyrosine kinase inhibitors used for the treatment of non-small cell lung carcinoma on cytochrome P450 2J2 activitiesAyaka Kojima, Masayuki Nadai, Norie Murayama, et al.
Internal Medicine (Tokyo, Japan)|November 20, 2024
Serum TARC Level as a Predictive Marker of Severe Disease in COVID-19 during the Omicron Variant Period of the PandemicTaisuke Isono, Ayaka Kojima, Takashi Nishida, et al.
Internal Medicine (Tokyo, Japan)|March 26, 2026
Risk Factors for Pneumonitis in Patients with Unresectable Advanced Non-small Cell Lung Cancer Treated with Immune Checkpoint InhibitorsTaisuke Isono, Akihiro Ishida, Yoko Onodera, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 21, 2022
Species and tissue differences in regorafenib glucuronidationAyaka Kojima, Masayuki Nadai, Miki Katoh
Drug Metabolism and Pharmacokinetics|February 9, 2025
Substrate inhibition potential of arachidonic acid on 14,15-epoxidation, a biological drug developmental target, mediated by recombinant human cytochrome P450 2J2 and 2C8 enzymesAyaka Kojima, Masayuki Nadai, Hiroshi Yamazaki, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 12, 2022
Species differences in oxidative metabolism of regorafenibAyaka Kojima, Ayuka Sogabe, Masayuki Nadai, et al.
Drug Metabolism and Pharmacokinetics|September 30, 2025
Tyrosine kinase inhibitors, nilotinib and radotinib, suppress both catalytic function and mRNA expression of human cytochrome P450 2J2 and 2C8Ayaka Kojima, Masayuki Nadai, Hiroshi Yamazaki, et al.
Angewandte Chemie (International Ed. in English)|January 31, 2014
A core-expanded subphthalocyanine analogue with a significantly distorted conjugated surface and unprecedented propertiesSoji Shimizu, Shota Nakano, Ayaka Kojima, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 17, 2022
Effects of multi-kinase inhibitors on the activity of cytochrome P450 2J2Ayaka Kojima, Masayuki Nadai, Norie Murayama, et al.
Biopharmaceutics & Drug Disposition|August 24, 2022
Changes in uridine 5'-diphospho-glucuronosyltransferase 1A6 expression by histone deacetylase inhibitor valproic acidYukiko Sakakibara, Ayaka Kojima, Yuki Asai, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 6, 2024
Effects of tyrosine kinase inhibitors used for the treatment of non-small cell lung carcinoma on cytochrome P450 2J2 activitiesAyaka Kojima, Masayuki Nadai, Norie Murayama, et al.
Internal Medicine (Tokyo, Japan)|November 20, 2024
Serum TARC Level as a Predictive Marker of Severe Disease in COVID-19 during the Omicron Variant Period of the PandemicTaisuke Isono, Ayaka Kojima, Takashi Nishida, et al.
Internal Medicine (Tokyo, Japan)|March 26, 2026
Risk Factors for Pneumonitis in Patients with Unresectable Advanced Non-small Cell Lung Cancer Treated with Immune Checkpoint InhibitorsTaisuke Isono, Akihiro Ishida, Yoko Onodera, et al.
Pageof 2